stage IVB mycosis fungoides/Sezary syndrome
Showing 51 - 75 of >10,000
Lymphoma Trial in Chicago (Gemcitabine, Pemetrexed)
Terminated
- Lymphoma
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Aug 20, 2019
Mycosis Fungoides Trial in Edmonton (Cemiplimab)
Not yet recruiting
- Mycosis Fungoides
-
Edmonton, Alberta, CanadaCross Cancer Institute
Sep 12, 2022
Refractory Mycosis Fungoides Trial in Scottsdale (drug, other, radiation)
Completed
- Refractory Mycosis Fungoides
- Aminolevulinic Acid Hydrochloride
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 3, 2023
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +99 more
- alemtuzumab
- +6 more
-
Denver, Colorado
- +6 more
Jan 15, 2020
Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)
Terminated
- Non-Hodgkin's Lymphoma
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 12, 2020
Cutaneous T-Cell Lymphoma Trial in United States (SGX301 (synthetic hypericin), Placebo)
Completed
- Cutaneous T-Cell Lymphoma
- SGX301 (synthetic hypericin)
- Placebo
-
Birmingham, Alabama
- +32 more
Mar 22, 2022
Low-Dose Total Skin Electron Therapy in Treating Refractory or
Recruiting
- Recurrent Mycosis Fungoides
- +4 more
- Quality-of-Life Assessment
- Objective Grading of Skin Findings
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 5, 2022
Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma
Recruiting
- Lymphoma, T-cell, Peripheral
- Lymphoma, T-cell, Cutaneous
-
Nagoya, Japan
- +2 more
Nov 24, 2022
Response to Gemcitabine Chemotherapy in Mycosis Fungoides
Recruiting
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides
- single-arm, non-randomized Biodynamic imaging (BDI)
-
Indianapolis, IndianaIndiana University School of Medicine, Department of Dermatology
Nov 16, 2022
Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)
Not yet recruiting
- Mycosis Fungoides
- Imiquimod
- Radiation Therapy
- (no location specified)
Apr 29, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Mogamulizumab
- Brentuximab vedotin
- (no location specified)
Dec 7, 2022
Mycosis Fungoides Trial in Leiden (Chlormethine)
Recruiting
- Mycosis Fungoides
-
Leiden, NetherlandsCentre for Human Drug Research
Mar 29, 2022
Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Stanford (KW-0761)
Completed
- Peripheral T-cell Lymphoma
- Cutaneous T-cell Lymphoma
- KW-0761
-
Stanford, CaliforniaStanford University
Dec 3, 2020
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Lymphoma Trial in Chicago (alemtuzumab)
Completed
- Lymphoma
- alemtuzumab
-
Chicago, Illinois
- +1 more
Feb 5, 2019
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)
Not yet recruiting
- T-cell Lymphoma
- +10 more
-
Chicago, IllinoisRush University Medical Center
Oct 24, 2022
Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)
Completed
- Peripheral T Cell Lymphoma
- +18 more
-
Vancouver, British Columbia, Canada
- +29 more
Apr 29, 2022
Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous
Active, not recruiting
- Epidermotropic T-cell Lymphomas
- HSCT
- Standard Care
-
Paris, FranceSaint Louis hospital
Apr 15, 2022
Skin Barrier and Microbiome of CTCL Patients
Not yet recruiting
- Lymphoma, T-Cell, Cutaneous
-
Leiden, NetherlandsCentre for Human Drug Research
Apr 21, 2023
T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)
Not yet recruiting
- T Cell Lymphoma
- Mogamulizumab
- DA-EPOCH Protocol
-
New Haven, ConnecticutYale Smilow Cancer Hospital
Aug 14, 2023
Cutaneous T-cell Lymphoma Trial in New York (Bexarotene, Total Skin Electron Beam (TSEB))
Recruiting
- Cutaneous T-cell Lymphoma
- Bexarotene
- Total Skin Electron Beam (TSEB)
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 19, 2022
ESCC Trial (Tislelizumab combined with chemoradiotherapy)
Not yet recruiting
- ESCC
- Tislelizumab combined with chemoradiotherapy
- (no location specified)
Sep 18, 2022
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021
Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)
Recruiting
- Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
- chlormethine gel
-
Bordeaux, France
- +1 more
Aug 17, 2022
Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)
Not yet recruiting
- Mycosis Fungoides
- Cutaneous T Cell Lymphoma
- Low-dose total-skin electron-beam therapy
- Phototherapy
- (no location specified)
Jan 24, 2022